| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 11,520 | $19.05 | $219,456.00 | -0.3% | -35.4% | +245.0% | |
| Dec 27, 2024 | Adeoye Y Olukotun52 | Director | Sell10b5-1 | 2,850 | $20.00 | $57,000.00 | -7.2% | -27.2% | +270.0% | |
| Dec 23, 2024 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 12,563 | $19.59 | $246,109.17 | -0.3% | -21.5% | +253.6% | |
| Dec 18, 2024 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 26,712 | $21.24 | $567,485.84 | -0.7% | -25.9% | +226.5% | |
| Dec 17, 2024 | William D. Waddill | Director | Sell10b5-1 | 7,495 | $21.97 | $164,665.08 | -15.7% | -30.0% | +191.0% | |
| Dec 17, 2024 | Douglas B Given66 | Director | Sell10b5-1 | 5,547 | $21.91 | $121,555.88 | -4.3% | -30.0% | +191.0% | |
| Dec 16, 2024 | Victoria Vakiener53 | Director | Sell10b5-1 | 8,994 | $21.91 | $197,058.54 | -29.8% | -30.3% | +189.0% | |
| Jul 2, 2024 | Tracie Oliver70 | Chief Commercial Officer | Sell10b5-1 | 9,394 | $25.28 | $237,480.32 | -6.9% | -23.2% | -33.0% | |
| May 2, 2024 | Victoria Vakiener53 | Director | Sell10b5-1 | 1,799 | $23.31 | $41,934.69 | -5.6% | +18.4% | -40.2% | |
| Apr 1, 2024 | James C Hamilton58 | Chief Discovery/ Trans Medicine | Sell | 6,000 | $28.03 | $168,180.00 | -2.8% | -7.8% | -56.8% |